Literature DB >> 6187966

[Nerve cell clonal lines in culture--models for studying the molecular basis of neuropharmacological actions].

H Herken.   

Abstract

Nerve cell lines with stable properties are isolated from neuroblastomas, glioblastomas or pheochromocytomas by periodic cloning using defined culture media. After the action of different drugs, these cells show all morphological and biochemical signs of differentiation and maturation. Depending on the origin of the clone, the cell lines synthesise typical neurotransmitters, which are stored in vesicles. It is demonstrated on cell lines which synthesise catecholamines that noradrenergic and dopaminergic clones are particularly suitable test objects for basic research in neuropharmacology.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187966     DOI: 10.1007/bf01484434

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  62 in total

1.  Effects of 6-aminonicotinamide on growth and acetylcholinesterase activity during differentiation of neuroblastoma cells in vitro.

Authors:  M Zeitz; K Lange; K Keller; H Herken
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-11       Impact factor: 3.000

2.  Metabolic consequences of drug-induced inhibition of the pentose phosphate pathway in neuroblastoma and glioma cells.

Authors:  H Kolbe; K Keller; K Lange; H Herken
Journal:  Biochem Biophys Res Commun       Date:  1976-11-22       Impact factor: 3.575

3.  Experimental neuropathy with Parkinson-like muscular rigidity. A suitable model for testing dopaminergic agonists and neuroleptic drugs.

Authors:  K Halbhübner; H Herken; D Loos
Journal:  Arzneimittelforschung       Date:  1978

4.  Purification and characterization of tyrosine hydroxylase from a clonal pheochromocytoma cell line.

Authors:  K A Markey; H Kondo; L Shenkman; M Goldstein
Journal:  Mol Pharmacol       Date:  1980-01       Impact factor: 4.436

5.  Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography.

Authors:  L J Felice; J D Felice; P T Kissinger
Journal:  J Neurochem       Date:  1978-12       Impact factor: 5.372

6.  Prostaglandin D2, a neuromodulator.

Authors:  T Shimizu; N Mizuno; T Amano; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

7.  Nerve growth factor in the nucleus: interaction with receptors on the nuclear membrane.

Authors:  B A Yankner; E M Shooter
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

8.  Mouse neuroblastoma clone N1E-115: a suitable model for studying the action of dopamine agonists of tyrosine hydroxylase activity.

Authors:  M Bräutigam; R Dreesen; C W Flosbach; H Herken
Journal:  Biochem Pharmacol       Date:  1982-04-01       Impact factor: 5.858

9.  Spastic paresis after 6-aminonicotinamide: metabolic disorders in the spinal cord and electromyographically recorded changes in the hind limbs of rats.

Authors:  H Herken; G Meyer-Estorf; K Halbhübner; D Loos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-06       Impact factor: 3.000

10.  DOPA metabolism in neuroblastoma.

Authors:  L Helson; G A Johnson; R Smith
Journal:  Med Pediatr Oncol       Date:  1980
View more
  2 in total

1.  Inhibition of striatal tyrosine hydroxylase by low concentrations of apomorphine.

Authors:  G Laschinski; B Kittner; M Bräutigam
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

2.  Inhibition of biopterin synthesis and DOPA production in PC-12 pheochromocytoma cells induced by 6-aminonicotinamide.

Authors:  W Jung; H Herken
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.